Pancreatic Cysts
Identify.
Track.
Impact.
82% of pancreatic cancers are diagnosed in advanced stages, limiting treatment options and making it one of the deadliest forms of cancer. With no screening process, this asymptomatic disease often goes unnoticed until it’s too late.
Eon Patient Management (EPM) platform is a best-in-class solution to identify incidental pancreatic abnormalities and longitudinally track patients who need serial surveillance to help detect this deadly disease in the early stages.
Unlock the power of incidental findings
The prevalence of incidental findings may astound you – 20% of all MRI scans performed in the US find potentially precancerous cysts. Even more alarming, over half of these patients don’t receive the necessary follow up care.
Capture abnormalities with 96.6% accuracy
By combining AI, longitudinal tracking, and care coordination, no other solution identifies and ensures more patients return for proactive treatment.
Champion stage shift in your community
For all stages combined,the 5-year relative survival rate for pancreatic cancer is 10%. With Eon, you can catch cancer in its earliest stages when it’s still treatable. Discover how Eon has delivered profound results for over 700 clients across the nation.
Significant downstream revenue
Proactive diagnosis not only saves lives, it can transform how oncology service lines grow. Eon captures all at-risk pancreas pathologies, not just pancreatic cysts — hypodense cystic lesions, tumors, pancreatic head masses, and more.
Case Study: The Dynamic Beginning of a Breakthrough Pancreas Program
In this case study, learn how a 500+ bed hospital partnered with Eon to:
• Grow their pancreatic cyst surveillance program by 375%, from 110 patients to 523 in just 12 months.
• Create stage shift by catching 65% of pancreatic cancers in early stages
“The ‘traditional’ style of pancreatic cyst surveillance is antiquated and misses a significant number of patients. To improve care quality, and increase early cancer detection at scale, using a powerful AI tool like Eon is essential.”
How many lives you could save by adding Eon Patient Management to your program? For a 300 bed hospital, we uncover an average of 350 patients annually with incidentally found pancreatic cysts and help 50% of those return for in-network care.
The table below shows the downstream financial impact of partnering with Eon. To receive a customized opportunity assessment, click here.
Ready to identify, track, and improve outcomes for patients at risk for future disease? Get started with your demo and ensure no patient falls through the cracks.